n (%) | |||
Asthma | No asthma | Total | |
N=81 (7.7) | N=975 (92.3) | N=1056 | |
Serotypes covered in vaccine formulations | |||
7-valent PCV | 44 (54.3) | 468 (48.0) | 512 (48.5) |
10-valent PCV | 59 (72.8) | 610 (62.6) | 669 (63.3) |
13-valent PCV | 64 (79.0) | 740 (75.9) | 804 (76.1) |
23-valent PPV* | 78 (96.3) | 903 (92.6) | 981 (92.9) |
23-valent PPV† | 73 (90.1) | 855 (87.7) | 928 (87.9) |